Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Health Indicator Report of Chlamydia Infections

Infections caused by the bacterium Chlamydia trachomatis are the most frequently reported notifiable disease in the United States. Chlamydia infections in both men and women are commonly asymptomatic, yet screenings occurring mostly among females produce higher rates of reported infections. Females with chlamydia infection are at risk for developing pelvic inflammatory disease (PID) and pregnant women with chlamydia can pass the infection to their infant during delivery, potentially resulting in pneumonia or neonatal ophthalmia. Both men and women may become infertile as a result of untreated chlamydia infections and susceptibility to more serious infections such as HIV also increases when an individual is infected with chlamydia.


This is Healthy New Jersey 2020 (HNJ2020) Objective STD-1. Numerator: Number of females aged 15-24 years with Chlamydia trachomatis infections ("tested anywhere") Denominator: Number of females aged 15-24 years in the population The Sexually Transmitted Disease Program (STDP) collects and compiles over 30,000 positive STD laboratory tests per year. The STDP has neither the authority nor the manpower to compel laboratories to report race or ethnicity, therefore data are not presented by race/ethnicity.

Data Source

Division of HIV/AIDS, STD and TB Services, New Jersey Department of Health, []


Incidence: Rate of newly reported chlamydia trachomatis infections by diagnosis date per 100,000 females aged 15-19 years Prevalence: Proportion of clinic patients aged 15-24 years found to have chlamydia trachomatis


Incidence: Number of newly reported chlamydia infections among females aged 15-19 years Prevalence: Number of clinic patients aged 15-24 years found to have chlamydia


Incidence: Total number of females aged 15-19 years in the population Prevalence: Total number of clinic patients aged 15-24 years who were screened

Healthy People Objective: Reduce the proportion of adolescents and young adults with Chlamydia trachomatis infections: Among females aged 15 to 24 years attending family planning clinics

U.S. Target: 6.7 percent

Other Objectives

'''Healthy New Jersey 2020 Objective STD-1''': Reduce the proportion of females aged 15-24 years with Chlamydia trachomatis infections (tested anywhere) to 2,726 per 100,000 female population aged 15-24 years. '''Healthy New Jersey 2020 Objective STD-2''': Reduce the proportion of persons aged 15-24 years who are screened at family planning and STD clinics and diagnosed with Chlamydia trachomatis infections to 8.8% among all persons, 3.9% among Whites, 13.7% among Blacks, 7.1% among Hispanics, and 7.0% among Asians.

What Is Being Done?

The [ NJDOH Sexually Transmitted Disease (STD) Program] strives to prevent and reduce the effects of STDs in New Jersey through prevention, education, screening, treatment, and surveillance. In cooperation with federal, state, and local partners, the STD Program provides: * Free, confidential testing and treatment for STDs * Data and surveillance services * Partner notification services and technical assistance * Technical assistance for the provision of STD prevention and treatment best practices * Education and training services and materials * Program evaluation * Management of health care service grants

Available Services

STD Testing Services: []

Health Program Information

NJDOH Sexually Transmitted Disease Program: []
Page Content Updated On 01/09/2018, Published on 01/09/2018
The information provided above is from the Department of Health's NJSHAD web site ( The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Fri, 20 July 2018 10:17:43 from Department of Health, New Jersey State Health Assessment Data Web site: ".

Content updated: Wed, 23 May 2018 05:01:08 EDT